Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2024

Open Access 01-12-2024 | Post-COVID Syndrome | Research

Longitudinal course and predictors of health-related quality of life, mental health, and fatigue, in non-hospitalized individuals with or without post COVID-19 syndrome

Authors: Inge Kirchberger, Christine Meisinger, Tobias D. Warm, Alexander Hyhlik-Dürr, Jakob Linseisen, Yvonne Goßlau

Published in: Health and Quality of Life Outcomes | Issue 1/2024

Login to get access

Abstract

Background

Long-term information on health-related quality of life (HRQOL) and mental health of non-hospitalized individuals with „post COVID-19 syndrome“ (PCS) is scarce. Thus, the objectives of the present study were to compare HRQOL and mental health of individuals with and without PCS in a German sample of non-hospitalized persons after SARS-CoV-2 infection, to characterize the long-term course up to 2 years and to identify predictors for post COVID-19 impairments.

Methods

Individuals with past SARS-CoV-2 infection were examined at the University Hospital of Augsburg from November 2020 to May 2021 and completed a postal questionnaire between June and November 2022. Participants who self-reported the presence of fatigue, dyspnea on exertion, memory problems or concentration problems were classified as having PCS. HRQOL was assessed using the Veterans RAND 12-Item Health Survey, mental health was measured by the Patient Health Questionnaire and the Fatigue Asessment Scale was used to assess fatigue severity. Multivariable linear regression models with inverse probability weighting were used to determine the association between PCS and health outcomes.

Results

From the 304 participants (58.2% women, median age 52 years), 210 (69.1%) were classified as having PCS in median 26 months after SARS-CoV-2 infection. Persons with PCS showed significantly more often depressive and anxiety disorders. PCS was independently and significantly associated with higher levels of depression, post-traumatic stress and fatigue, as well as poorer physical and mental HRQOL in median 9 months as well as 26 months after SARS-CoV-2 infection. A large number of acute symptoms and a prior diagnosis of depression were independently associated with poor mental health and HRQOL. While post-traumatic stress and mental HRQOL improved from 9 months to 26 months post infection onset, depressiveness, fatigue and physical HRQOL remained stable in both, persons with and without PCS.

Conclusions

PCS in non-hospitalized persons after SARS-CoV-2 infection is often associated with long-term impairments of mental health and HRQOL outcomes.
Literature
2.
go back to reference Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and Meta-analysis of one-year Follow-Up studies on Post-COVID symptoms. Pathogens. 2022;11:269.CrossRefPubMedPubMedCentral Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and Meta-analysis of one-year Follow-Up studies on Post-COVID symptoms. Pathogens. 2022;11:269.CrossRefPubMedPubMedCentral
3.
go back to reference Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593–607.CrossRefPubMed Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593–607.CrossRefPubMed
4.
go back to reference Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604–15.CrossRefPubMedCentral Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604–15.CrossRefPubMedCentral
7.
go back to reference Förster C, Colombo MG, Wetzel AJ, Martus P, Joos S. Persisting symptoms after COVID-19. Dtsch Arztebl Int. 2022;119:167–74.PubMedPubMedCentral Förster C, Colombo MG, Wetzel AJ, Martus P, Joos S. Persisting symptoms after COVID-19. Dtsch Arztebl Int. 2022;119:167–74.PubMedPubMedCentral
8.
go back to reference Augustin M, Schommers P, Stecher M et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021:100122. Augustin M, Schommers P, Stecher M et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021:100122.
9.
go back to reference Lackermair K, Wilhelm K, William F, et al. The prevalence of persistent symptoms after COVID-19 disease. Dtsch Arztebl Int. 2022;119:175–6.PubMedPubMedCentral Lackermair K, Wilhelm K, William F, et al. The prevalence of persistent symptoms after COVID-19 disease. Dtsch Arztebl Int. 2022;119:175–6.PubMedPubMedCentral
10.
go back to reference Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42.
11.
go back to reference Parker AM, Brigham E, Connolly B, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9:1328–41.CrossRefPubMedPubMedCentral Parker AM, Brigham E, Connolly B, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9:1328–41.CrossRefPubMedPubMedCentral
13.
go back to reference Yuan N, Lv ZH, Sun CR, Wen YY, Tao TY, Qian D, Tao FP, Yu JH. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Front Public Health. 2023;11:1112383.CrossRefPubMedPubMedCentral Yuan N, Lv ZH, Sun CR, Wen YY, Tao TY, Qian D, Tao FP, Yu JH. Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Front Public Health. 2023;11:1112383.CrossRefPubMedPubMedCentral
14.
go back to reference Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.CrossRefPubMedPubMedCentral Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.CrossRefPubMedPubMedCentral
15.
go back to reference Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-term effects of COVID-19 on mental health: a systematic review. J Affect Disord. 2022;299:118–25.CrossRefPubMed Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-term effects of COVID-19 on mental health: a systematic review. J Affect Disord. 2022;299:118–25.CrossRefPubMed
16.
go back to reference Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129–37.CrossRefPubMedPubMedCentral Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129–37.CrossRefPubMedPubMedCentral
17.
go back to reference Stallmach A, Katzer K, Besteher B, et al. Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study. Infection. 2023;51:337–45.CrossRefPubMed Stallmach A, Katzer K, Besteher B, et al. Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study. Infection. 2023;51:337–45.CrossRefPubMed
19.
go back to reference Houben-Wilke S, Goërtz YM, Delbressine JM, Vaes AW, Meys R, Machado FV, van Herck M, Burtin C, Posthuma R, Franssen FM, Vijlbrief H, Spies Y, van ‘t Hul AJ, Spruit MA, Janssen DJ. The impact of long COVID-19 on Mental Health: Observational 6-Month Follow-Up study. JMIR Ment Health. 2022;9:e33704. https://doi.org/10.2196/33704.CrossRefPubMedPubMedCentral Houben-Wilke S, Goërtz YM, Delbressine JM, Vaes AW, Meys R, Machado FV, van Herck M, Burtin C, Posthuma R, Franssen FM, Vijlbrief H, Spies Y, van ‘t Hul AJ, Spruit MA, Janssen DJ. The impact of long COVID-19 on Mental Health: Observational 6-Month Follow-Up study. JMIR Ment Health. 2022;9:e33704. https://​doi.​org/​10.​2196/​33704.CrossRefPubMedPubMedCentral
20.
go back to reference Janiri D, Carfì A, Kotzalidis GD, Bernabei R, Landi F, Sani G, Gemelli Against COVID-19 Post-Acute Care Study Group. Posttraumatic stress disorder in patients after severe COVID-19 infection. JAMA Psychiatry. 2021;78:567–9.CrossRefPubMedPubMedCentral Janiri D, Carfì A, Kotzalidis GD, Bernabei R, Landi F, Sani G, Gemelli Against COVID-19 Post-Acute Care Study Group. Posttraumatic stress disorder in patients after severe COVID-19 infection. JAMA Psychiatry. 2021;78:567–9.CrossRefPubMedPubMedCentral
21.
go back to reference Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022;94:253–62.CrossRefPubMed Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022;94:253–62.CrossRefPubMed
23.
go back to reference Meisinger C, Kirchberger I, Warm TD, Hyhlik-Dürr A, Goßlau Y, Linseisen J. Elevated plasma D-dimer concentrations in adults after an outpatient-treated COVID-19 infection. Viruses. 2022;14:2441.CrossRefPubMedPubMedCentral Meisinger C, Kirchberger I, Warm TD, Hyhlik-Dürr A, Goßlau Y, Linseisen J. Elevated plasma D-dimer concentrations in adults after an outpatient-treated COVID-19 infection. Viruses. 2022;14:2441.CrossRefPubMedPubMedCentral
24.
go back to reference Kirchberger I, Peilstöcker D, Warm TD, et al. Subjective and objective cognitive impairments in non-hospitalized persons 9 months after SARS-CoV-2 infection. Viruses. 2023;15:256.CrossRefPubMedPubMedCentral Kirchberger I, Peilstöcker D, Warm TD, et al. Subjective and objective cognitive impairments in non-hospitalized persons 9 months after SARS-CoV-2 infection. Viruses. 2023;15:256.CrossRefPubMedPubMedCentral
26.
go back to reference Kroenke K, Spitzer RL, Williams JBW, Löwe B. The Patient Health Questionnaire somatic, anxiety, and depressive Symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32:345–59.CrossRefPubMed Kroenke K, Spitzer RL, Williams JBW, Löwe B. The Patient Health Questionnaire somatic, anxiety, and depressive Symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32:345–59.CrossRefPubMed
27.
go back to reference Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37:67–75.CrossRefPubMed Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37:67–75.CrossRefPubMed
28.
go back to reference Löwe B, Gräfe K, Quenter A, Zipfel S, Herzog W. Screening psychischer Störung Mit dem Gesundheitsfragebogen für Patienten (PHQD) Ergebnisse Der Deutschen Validierungsstudie. Diagnostica. 2004;50:171–81.CrossRef Löwe B, Gräfe K, Quenter A, Zipfel S, Herzog W. Screening psychischer Störung Mit dem Gesundheitsfragebogen für Patienten (PHQD) Ergebnisse Der Deutschen Validierungsstudie. Diagnostica. 2004;50:171–81.CrossRef
29.
go back to reference Rosner R, Hagl M. Die revidierte impact of event-skala (IES-R). Psychosom Konsiliarpsychiatr. 2008;2:240–3.CrossRef Rosner R, Hagl M. Die revidierte impact of event-skala (IES-R). Psychosom Konsiliarpsychiatr. 2008;2:240–3.CrossRef
30.
go back to reference Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure the fatigue Assessment Scale. J Psychosom Res. 2003;54:345–52.CrossRefPubMed Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure the fatigue Assessment Scale. J Psychosom Res. 2003;54:345–52.CrossRefPubMed
31.
go back to reference Mead G, Lynch J, Greig C, Young A, Lewis S, Sharpe M. Evaluation of fatigue scales in stroke patients. Stroke. 2007;38:2090–5.CrossRefPubMed Mead G, Lynch J, Greig C, Young A, Lewis S, Sharpe M. Evaluation of fatigue scales in stroke patients. Stroke. 2007;38:2090–5.CrossRefPubMed
32.
go back to reference Cumming TB, Mead G. Classifying post-stroke fatigue: optimal cut-off on the fatigue Assessment Scale. J Psychosom Res. 2017;103:147–9.CrossRefPubMed Cumming TB, Mead G. Classifying post-stroke fatigue: optimal cut-off on the fatigue Assessment Scale. J Psychosom Res. 2017;103:147–9.CrossRefPubMed
33.
go back to reference Hüppe M, Schneider K, Casser HR, Knille A, Kohlmann T, Lindena G, Nagel B, Nelles J, Pfingsten M, Petzke F. Kennwerte und teststatistische Güte Des Veterans RAND 12-Item Health Survey (VR-12) bei Patienten Mit Chronischem Schmerz: Eine Auswertung auf basis des KEDOQ-Schmerz-datensatzes. Der Schmerz. 2021;6:109–20. Hüppe M, Schneider K, Casser HR, Knille A, Kohlmann T, Lindena G, Nagel B, Nelles J, Pfingsten M, Petzke F. Kennwerte und teststatistische Güte Des Veterans RAND 12-Item Health Survey (VR-12) bei Patienten Mit Chronischem Schmerz: Eine Auswertung auf basis des KEDOQ-Schmerz-datensatzes. Der Schmerz. 2021;6:109–20.
34.
go back to reference Cohen J. Statistical Power Analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates,; 1988. Cohen J. Statistical Power Analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates,; 1988.
35.
go back to reference Gaspar P, Dias M, Parreira I, Gonçalves HD, Parlato F, Maione V, Atalaia Barbacena H, Carreiro C, Duarte L. Predictors of Long-COVID-19 and its impact on quality of life: longitudinal analysis at 3, 6 and 9 months after discharge from a Portuguese centre. Acta Med Port. 2023;24. https://doi.org/10.20344/amp.19047. Gaspar P, Dias M, Parreira I, Gonçalves HD, Parlato F, Maione V, Atalaia Barbacena H, Carreiro C, Duarte L. Predictors of Long-COVID-19 and its impact on quality of life: longitudinal analysis at 3, 6 and 9 months after discharge from a Portuguese centre. Acta Med Port. 2023;24. https://​doi.​org/​10.​20344/​amp.​19047.
36.
go back to reference Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, Scheibenbogen C, Rabe KF, Maetzler W, Maetzler C, Laudien M, Frank D, Ballhausen S, Hermes A, Miljukov O, Haeusler KG, Mokhtari NEE, Witzenrath M, Vehreschild JJ, Krefting D, Pape D, Montellano FA, Kohls M, Morbach C, Störk S, Reese JP, Keil T, Heuschmann P, Krawczak M, Schreiber S, NAPKON study group. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549.CrossRefPubMedPubMedCentral Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, Scheibenbogen C, Rabe KF, Maetzler W, Maetzler C, Laudien M, Frank D, Ballhausen S, Hermes A, Miljukov O, Haeusler KG, Mokhtari NEE, Witzenrath M, Vehreschild JJ, Krefting D, Pape D, Montellano FA, Kohls M, Morbach C, Störk S, Reese JP, Keil T, Heuschmann P, Krawczak M, Schreiber S, NAPKON study group. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549.CrossRefPubMedPubMedCentral
37.
go back to reference Goldberg X, Castaño-Vinyals G, Espinosa A, Carreras A, Liutsko L, Sicuri E, Foraster M, O’Callaghan-Gordo C, Dadvand P, Moncunill G, Dobaño C, Cortés B, Pleguezuelos V, Straif K, Garcia-Aymerich J, de Cid R, Cardis E, Kogevinas M. Mental health and COVID-19 in a general population cohort in Spain (COVICAT study). Soc Psychiatry Psychiatr Epidemiol. 2022;57:2457–68.CrossRefPubMedPubMedCentral Goldberg X, Castaño-Vinyals G, Espinosa A, Carreras A, Liutsko L, Sicuri E, Foraster M, O’Callaghan-Gordo C, Dadvand P, Moncunill G, Dobaño C, Cortés B, Pleguezuelos V, Straif K, Garcia-Aymerich J, de Cid R, Cardis E, Kogevinas M. Mental health and COVID-19 in a general population cohort in Spain (COVICAT study). Soc Psychiatry Psychiatr Epidemiol. 2022;57:2457–68.CrossRefPubMedPubMedCentral
38.
go back to reference Lemhöfer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C. The impact of Post-COVID-Syndrome on functioning - results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol. 2021;16:45.CrossRefPubMedPubMedCentral Lemhöfer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C. The impact of Post-COVID-Syndrome on functioning - results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol. 2021;16:45.CrossRefPubMedPubMedCentral
39.
go back to reference Streit F, Zillich L, Frank J, Kleineidam L, Wagner M, Baune BT, Klinger-König J, Grabe HJ, Pabst A, Riedel-Heller SG, Schmiedek F, Schmidt B, Erhardt A, Deckert J, NAKO I, Rietschel M, Berger K. Lifetime and current depression in the German National Cohort (NAKO). World J Biol Psychiatry. 2023;24(10):865–80.CrossRefPubMed Streit F, Zillich L, Frank J, Kleineidam L, Wagner M, Baune BT, Klinger-König J, Grabe HJ, Pabst A, Riedel-Heller SG, Schmiedek F, Schmidt B, Erhardt A, Deckert J, NAKO I, Rietschel M, Berger K. Lifetime and current depression in the German National Cohort (NAKO). World J Biol Psychiatry. 2023;24(10):865–80.CrossRefPubMed
40.
go back to reference Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho SM. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162.CrossRefPubMedPubMedCentral Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho SM. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162.CrossRefPubMedPubMedCentral
41.
go back to reference Roth PH, Gadebusch-Bondio M. The contested meaning of long COVID - patients, doctors, and the politics of subjective evidence. Soc Sci Med. 2022;292:114619.CrossRefPubMed Roth PH, Gadebusch-Bondio M. The contested meaning of long COVID - patients, doctors, and the politics of subjective evidence. Soc Sci Med. 2022;292:114619.CrossRefPubMed
Metadata
Title
Longitudinal course and predictors of health-related quality of life, mental health, and fatigue, in non-hospitalized individuals with or without post COVID-19 syndrome
Authors
Inge Kirchberger
Christine Meisinger
Tobias D. Warm
Alexander Hyhlik-Dürr
Jakob Linseisen
Yvonne Goßlau
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2024
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-024-02245-y

Other articles of this Issue 1/2024

Health and Quality of Life Outcomes 1/2024 Go to the issue